Literature DB >> 35222618

Sign-based Shrinkage Based on an Asymmetric LASSO Penalty.

Eric S Kawaguchi1, Burcu F Darst1, Kan Wang2, David V Conti1.   

Abstract

Penalized regression provides an automated approach to preform simultaneous variable selection and parameter estimation and is a popular method to analyze high-dimensional data. Since the conception of the LASSO in the mid-to-late 1990s, extensive research has been done to improve penalized regression. The LASSO, and several of its variations, performs penalization symmetrically around zero. Thus, variables with the same magnitude are shrunk the same regardless of the direction of effect. To the best of our knowledge, sign-based shrinkage, preferential shrinkage based on the sign of the coefficients, has yet to be explored under the LASSO framework. We propose a generalization to the LASSO, asymmetric LASSO, that performs sign-based shrinkage. Our method is motivated by placing an asymmetric Laplace prior on the regression coefficients, rather than a symmetric Laplace prior. This corresponds to an asymmetric ℓ 1 penalty under the penalized regression framework. In doing so, preferential shrinkage can be performed through an auxiliary tuning parameter that controls the degree of asymmetry. Our numerical studies indicate that the asymmetric LASSO performs better than the LASSO when effect sizes are sign skewed. Furthermore, in the presence of positively-skewed effects, the asymmetric LASSO is comparable to the non-negative LASSO without the need to place an a priori constraint on the effect estimates and outperforms the non-negative LASSO when negative effects are also present in the model. A real data example using the breast cancer gene expression data from The Cancer Genome Atlas is also provided, where the asymmetric LASSO identifies two potentially novel gene expressions that are associated with BRCA1 with a minor improvement in prediction performance over the LASSO and non-negative LASSO.

Entities:  

Keywords:  asymmetric Laplace distribution; high-dimensional statistics; penalized regression; quantile regularization; variable selection

Year:  2021        PMID: 35222618      PMCID: PMC8880910          DOI: 10.6339/21-JDS1015

Source DB:  PubMed          Journal:  J Data Sci        ISSN: 1680-743X


  22 in total

1.  A transcriptome analysis by lasso penalized Cox regression for pancreatic cancer survival.

Authors:  Tong Tong Wu; Haijun Gong; Edmund M Clarke
Journal:  J Bioinform Comput Biol       Date:  2011-12       Impact factor: 1.122

2.  Molecular cloning and characterization of a human homologue of TBPIP, a BRCA1 locus-related gene.

Authors:  H Ijichi; T Tanaka; T Nakamura; H Yagi; A Hakuba; M Sato
Journal:  Gene       Date:  2000-05-02       Impact factor: 3.688

3.  Marginal false discovery rates for penalized regression models.

Authors:  Patrick J Breheny
Journal:  Biostatistics       Date:  2019-04-01       Impact factor: 5.899

Review 4.  BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Authors:  P L Welcsh; M C King
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

6.  Strong rules for discarding predictors in lasso-type problems.

Authors:  Robert Tibshirani; Jacob Bien; Jerome Friedman; Trevor Hastie; Noah Simon; Jonathan Taylor; Ryan J Tibshirani
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2012-03       Impact factor: 4.488

7.  Tumor mutation burden and JARID2 gene alteration are associated with short disease-free survival in locally advanced triple-negative breast cancer.

Authors:  Xiangmei Zhang; Jingping Li; Qing Yang; Yanfang Wang; Xinhui Li; Yunjiang Liu; Baoen Shan
Journal:  Ann Transl Med       Date:  2020-09

8.  Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway.

Authors:  Jian Cao; Huiling Li; Guangquan Liu; Suping Han; Pengfei Xu
Journal:  Mol Med Rep       Date:  2017-07-17       Impact factor: 2.952

9.  Classification and selection of biomarkers in genomic data using LASSO.

Authors:  Debashis Ghosh; Arul M Chinnaiyan
Journal:  J Biomed Biotechnol       Date:  2005-06-30

10.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.

Authors:  Amit V Khera; Mark Chaffin; Krishna G Aragam; Mary E Haas; Carolina Roselli; Seung Hoan Choi; Pradeep Natarajan; Eric S Lander; Steven A Lubitz; Patrick T Ellinor; Sekar Kathiresan
Journal:  Nat Genet       Date:  2018-08-13       Impact factor: 38.330

View more
  1 in total

1.  Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach.

Authors:  Fabienne Englmeier; Annalen Bleckmann; Wolfgang Brückl; Frank Griesinger; Annette Fleitz; Klaus Nagels
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-09       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.